Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01523275 · ClinicalTrials.gov registry record · NA
Study of Mitomycin-C Application in Laryngotracheal Stenosis
A NA study, sponsored by University of California, San Francisco.
- Terminated
- Registry status
- NA
- Development phase
- 15
- Enrollment target
NCT01523275 is a NA study that was terminated before completion, run by University of California, San Francisco. The registered enrollment target is 15 participants.
The verdict
NCT01523275, a NA study, was terminated before completion, sponsored by University of California, San Francisco.
- TERMINATED
- Registry status
- NA
- Development phase
- 15 participants
- Enrollment target
Study Summary
This is a randomized, prospective, double-blind, placebo-controlled clinical trial of the use of mitomycin-C topical application as an adjunctive treatment in the endoscopic surgical treatment of patients with laryngotracheal stenosis. We hypothesize that the use of mitomycin-C improves patient outcome in the endoscopic surgical treatment of laryngotracheal stenosis.
Interventions
- DRUG Mitomycin -C
- OTHER Saline application
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 15 participants |
| Start Date | 2012-08 |
| Est. Completion | 2018-02 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01523275
The ClinicalTrials.gov registry entry for NCT01523275 describes a study currently listed as terminated, categorized as NA. The registered enrollment target is 15 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of California, San Francisco, which has 1,713 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Mitomycin -C is the first listed.
NCT01523275 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01523275 about?
NCT01523275 is a clinical study titled "Study of Mitomycin-C Application in Laryngotracheal Stenosis". This is a randomized, prospective, double-blind, placebo-controlled clinical trial of the use of mitomycin-C topical application as an adjunctive treatment in the endoscopic surgical treatment of patients with laryngotracheal stenosis. We hypothesize that the use of mitomycin-C improves patient outc...
What is the current status of trial NCT01523275?
This trial is currently terminated. It is a NA study. The enrollment target is 15 participants. The study started on 2012-08. Estimated completion is 2018-02.
What interventions are being tested in trial NCT01523275?
The interventions under investigation include: Mitomycin -C (DRUG), Saline application (OTHER).
Who is sponsoring clinical trial NCT01523275?
This trial is sponsored by University of California, San Francisco, which has 1,713 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.